{"transactions":[{"id":1856969,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2023-06-14T01:20:59.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":49231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":161906,"derivative":{"exercise_price":8.39,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":49231},"source":{"system":"sec-edgar","filing":"0001367644-23-000121","document":"wk-form4_1686705651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000121/wk-form4_1686705651.xml","form_type":"4"}},{"id":1856968,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-06-14T01:20:59.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":49231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":174398,"source":{"system":"sec-edgar","filing":"0001367644-23-000121","document":"wk-form4_1686705651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000121/wk-form4_1686705651.xml","form_type":"4"}},{"id":1856967,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-06-14T01:20:59.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":24616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan.  These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":125167,"source":{"system":"sec-edgar","filing":"0001367644-23-000121","document":"wk-form4_1686705651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000121/wk-form4_1686705651.xml","form_type":"4"}},{"id":1968536,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-07T00:37:20.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":112675,"derivative":{"exercise_price":12.06,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":12308},"source":{"system":"sec-edgar","filing":"0001367644-23-000072","document":"wf-form4_167814943048288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000072/wf-form4_167814943048288.xml","form_type":"4"}},{"id":1968535,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-03-07T00:37:20.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":100551,"source":{"system":"sec-edgar","filing":"0001367644-23-000072","document":"wf-form4_167814943048288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000072/wf-form4_167814943048288.xml","form_type":"4"}},{"id":1968534,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-03-07T00:37:20.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":6154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan.  These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":88243,"source":{"system":"sec-edgar","filing":"0001367644-23-000072","document":"wf-form4_167814943048288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000072/wf-form4_167814943048288.xml","form_type":"4"}},{"id":1978871,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-03-02T19:41:44.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":998,"price":12.38,"value":12355.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":33927,"source":{"system":"sec-edgar","filing":"0001367644-23-000054","document":"wf-form4_167778608843186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000054/wf-form4_167778608843186.xml","form_type":"4"}},{"id":1989845,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-02-28T01:22:23.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":812,"price":13.71,"value":11132.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":33681,"source":{"system":"sec-edgar","filing":"0001367644-23-000033","document":"wf-form4_167754732777822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000033/wf-form4_167754732777822.xml","form_type":"4"}},{"id":1989844,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-02-28T01:22:23.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":432,"price":14.3,"value":6177.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":34493,"source":{"system":"sec-edgar","filing":"0001367644-23-000033","document":"wf-form4_167754732777822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000033/wf-form4_167754732777822.xml","form_type":"4"}},{"id":2022348,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-02-11T01:34:32.000Z","date":"2023-02-08","kind":"tax_withholding","acquired":false,"shares":1964,"price":13.25,"value":26023.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":34925,"source":{"system":"sec-edgar","filing":"0001367644-23-000013","document":"wf-form4_167607925563475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000013/wf-form4_167607925563475.xml","form_type":"4"}},{"id":2022347,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2023-02-11T01:34:32.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":95,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 5,792 shares of common stock, which is in excess of the 5,697 shares previously reported on February 25, 2020."}],"balance_after":36889,"source":{"system":"sec-edgar","filing":"0001367644-23-000013","document":"wf-form4_167607925563475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000013/wf-form4_167607925563475.xml","form_type":"4"}},{"id":2359775,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-03-03T00:25:15.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":42289,"price":41.38,"value":1749918.82,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":42289,"derivative":{"exercise_price":41.38,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":42289},"source":{"system":"sec-edgar","filing":"0001367644-22-000043","document":"wf-form4_164626708631194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000043/wf-form4_164626708631194.xml","form_type":"4"}},{"id":2359774,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2022-03-03T00:25:15.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":739,"price":39.64,"value":29293.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":86200,"source":{"system":"sec-edgar","filing":"0001367644-22-000043","document":"wf-form4_164626708631194.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000043/wf-form4_164626708631194.xml","form_type":"4"}},{"id":2359773,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2022-03-03T00:25:15.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":17822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":86939,"source":{"system":"sec-edgar","filing":"0001367644-22-000043","document":"wf-form4_164626708631194.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000043/wf-form4_164626708631194.xml","form_type":"4"}},{"id":2359772,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2022-03-03T00:25:15.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":32323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (10,573 shares) or on the day prior to the second anniversary date of the grant (21,750 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":69117,"source":{"system":"sec-edgar","filing":"0001367644-22-000043","document":"wf-form4_164626708631194.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000043/wf-form4_164626708631194.xml","form_type":"4"}},{"id":2371535,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2022-02-25T22:17:18.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":828,"price":42.47,"value":35165.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the company in exchange for payment of the employee's withholding taxes."}],"balance_after":36794,"source":{"system":"sec-edgar","filing":"0001367644-22-000030","document":"wf-form4_164582741558623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000030/wf-form4_164582741558623.xml","form_type":"4"}},{"id":2371534,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2022-02-25T22:17:18.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":424,"price":42.23,"value":17905.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the company in exchange for payment of the employee's withholding taxes."}],"balance_after":37622,"source":{"system":"sec-edgar","filing":"0001367644-22-000030","document":"wf-form4_164582741558623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000030/wf-form4_164582741558623.xml","form_type":"4"}},{"id":2374231,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2022-02-24T23:49:57.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":1980,"price":42.23,"value":83615.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":38046,"source":{"system":"sec-edgar","filing":"0001367644-22-000016","document":"wf-form4_164574658105150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000016/wf-form4_164574658105150.xml","form_type":"4"}},{"id":2374230,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2022-02-24T23:49:57.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":1836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 6,917 shares of common stock, which is in excess of the 5,081 shares previously reported on February 28, 2019."}],"balance_after":40026,"source":{"system":"sec-edgar","filing":"0001367644-22-000016","document":"wf-form4_164574658105150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000016/wf-form4_164574658105150.xml","form_type":"4"}},{"id":2811971,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-03-03T23:07:30.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":20145,"price":99.02,"value":1994757.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":0,"derivative":{"exercise_price":49.64,"expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":20145},"source":{"system":"sec-edgar","filing":"0001367644-21-000049","document":"wf-form4_161481282979100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000049/wf-form4_161481282979100.xml","form_type":"4"}},{"id":2811970,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-03-03T23:07:30.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":17134,"price":99.62,"value":1706889.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":0,"derivative":{"exercise_price":30.63,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":17134},"source":{"system":"sec-edgar","filing":"0001367644-21-000049","document":"wf-form4_161481282979100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000049/wf-form4_161481282979100.xml","form_type":"4"}},{"id":2811969,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-03-03T23:07:30.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":20145,"price":99.02,"value":1994757.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99."}],"balance_after":38190,"source":{"system":"sec-edgar","filing":"0001367644-21-000049","document":"wf-form4_161481282979100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000049/wf-form4_161481282979100.xml","form_type":"4"}},{"id":2811968,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-03-03T23:07:30.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":20145,"price":49.64,"value":999997.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":58335,"source":{"system":"sec-edgar","filing":"0001367644-21-000049","document":"wf-form4_161481282979100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000049/wf-form4_161481282979100.xml","form_type":"4"}},{"id":2811967,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-03-03T23:07:30.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":17134,"price":99.62,"value":1706889.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25."}],"balance_after":38190,"source":{"system":"sec-edgar","filing":"0001367644-21-000049","document":"wf-form4_161481282979100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000049/wf-form4_161481282979100.xml","form_type":"4"}},{"id":2811966,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-03-03T23:07:30.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":17134,"price":30.63,"value":524814.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":55324,"source":{"system":"sec-edgar","filing":"0001367644-21-000049","document":"wf-form4_161481282979100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000049/wf-form4_161481282979100.xml","form_type":"4"}},{"id":2829181,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-26T22:18:16.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":14973,"price":93.49,"value":1399825.77,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":14973,"derivative":{"exercise_price":93.49,"expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":14973},"source":{"system":"sec-edgar","filing":"0001367644-21-000047","document":"wf-form4_161437785866552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000047/wf-form4_161437785866552.xml","form_type":"4"}},{"id":2829180,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-02-26T22:18:16.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":732,"price":97.15,"value":71113.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":38190,"source":{"system":"sec-edgar","filing":"0001367644-21-000047","document":"wf-form4_161437785866552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000047/wf-form4_161437785866552.xml","form_type":"4"}},{"id":2829179,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-02-26T22:18:16.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":739,"price":97.15,"value":71793.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":38922,"source":{"system":"sec-edgar","filing":"0001367644-21-000047","document":"wf-form4_161437785866552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000047/wf-form4_161437785866552.xml","form_type":"4"}},{"id":2829178,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-02-26T22:18:16.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":847,"price":93.49,"value":79186.03,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":39661,"source":{"system":"sec-edgar","filing":"0001367644-21-000047","document":"wf-form4_161437785866552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000047/wf-form4_161437785866552.xml","form_type":"4"}},{"id":2829177,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-02-26T22:18:16.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":3744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":40508,"source":{"system":"sec-edgar","filing":"0001367644-21-000047","document":"wf-form4_161437785866552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000047/wf-form4_161437785866552.xml","form_type":"4"}},{"id":2829176,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-02-26T22:18:16.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":3744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":36764,"source":{"system":"sec-edgar","filing":"0001367644-21-000047","document":"wf-form4_161437785866552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000047/wf-form4_161437785866552.xml","form_type":"4"}},{"id":2866125,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-02-12T02:24:13.000Z","date":"2021-02-09","kind":"tax_withholding","acquired":false,"shares":2183,"price":123.45,"value":269491.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 4,285 PSUs were previously reported, of which only 2,714 vested on February 11, 2020."}],"balance_after":33020,"source":{"system":"sec-edgar","filing":"0001367644-21-000018","document":"wf-form4_161309662486709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000018/wf-form4_161309662486709.xml","form_type":"4"}},{"id":2866124,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2021-02-12T02:24:13.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":2518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,554 shares of common stock, which is in excess of the 5,036 shares previously reported on March 1, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,554 shares of common stock, which is in excess of the 5,036 shares previously reported on March 1, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 4,285 PSUs were previously reported, of which only 2,714 vested on February 11, 2020."}],"balance_after":35203,"source":{"system":"sec-edgar","filing":"0001367644-21-000018","document":"wf-form4_161309662486709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000018/wf-form4_161309662486709.xml","form_type":"4"}},{"id":3172247,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-04-21T22:12:10.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":17009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of options granted under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":80384,"derivative":{"exercise_price":30.86,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":17009},"source":{"system":"sec-edgar","filing":"0001367644-20-000037","document":"wf-form4_158750711233940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000037/wf-form4_158750711233940.xml","form_type":"4"}},{"id":3172246,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-04-21T22:12:10.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":20414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of options granted under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":97393,"derivative":{"exercise_price":26.45,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":20414},"source":{"system":"sec-edgar","filing":"0001367644-20-000037","document":"wf-form4_158750711233940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000037/wf-form4_158750711233940.xml","form_type":"4"}},{"id":3172245,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-04-21T22:12:10.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":17009,"price":69,"value":1173621.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":34256,"source":{"system":"sec-edgar","filing":"0001367644-20-000037","document":"wf-form4_158750711233940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000037/wf-form4_158750711233940.xml","form_type":"4"}},{"id":3172244,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-04-21T22:12:10.000Z","date":"2020-04-20","kind":"exercise","acquired":true,"shares":17009,"price":30.86,"value":524897.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":51265,"source":{"system":"sec-edgar","filing":"0001367644-20-000037","document":"wf-form4_158750711233940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000037/wf-form4_158750711233940.xml","form_type":"4"}},{"id":3172243,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-04-21T22:12:10.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":20414,"price":65,"value":1326910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":34256,"source":{"system":"sec-edgar","filing":"0001367644-20-000037","document":"wf-form4_158750711233940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000037/wf-form4_158750711233940.xml","form_type":"4"}},{"id":3172242,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-04-21T22:12:10.000Z","date":"2020-04-17","kind":"exercise","acquired":true,"shares":20414,"price":26.45,"value":539950.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":54670,"source":{"system":"sec-edgar","filing":"0001367644-20-000037","document":"wf-form4_158750711233940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000037/wf-form4_158750711233940.xml","form_type":"4"}},{"id":3179556,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-04-09T00:22:14.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":3730,"price":60,"value":223800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":34256,"source":{"system":"sec-edgar","filing":"0001367644-20-000035","document":"wf-form4_158639171266875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000035/wf-form4_158639171266875.xml","form_type":"4"}},{"id":3179555,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-04-09T00:22:14.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":4242,"price":60,"value":254520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":37986,"source":{"system":"sec-edgar","filing":"0001367644-20-000035","document":"wf-form4_158639171266875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000035/wf-form4_158639171266875.xml","form_type":"4"}},{"id":3243409,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-02-28T02:23:21.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":22784,"price":61.44,"value":1399848.96,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":43105,"derivative":{"exercise_price":61.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":22784},"source":{"system":"sec-edgar","filing":"0001367644-20-000019","document":"wf-form4_158285658301395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000019/wf-form4_158285658301395.xml","form_type":"4"}},{"id":3243408,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-02-28T02:23:21.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":409,"price":58.42,"value":23893.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."}],"balance_after":42228,"source":{"system":"sec-edgar","filing":"0001367644-20-000019","document":"wf-form4_158285658301395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000019/wf-form4_158285658301395.xml","form_type":"4"}},{"id":3243407,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-02-28T02:23:21.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":484,"price":59.91,"value":28996.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."}],"balance_after":42637,"source":{"system":"sec-edgar","filing":"0001367644-20-000019","document":"wf-form4_158285658301395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000019/wf-form4_158285658301395.xml","form_type":"4"}},{"id":3243406,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-02-28T02:23:21.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":513,"price":59.91,"value":30733.83,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."}],"balance_after":43121,"source":{"system":"sec-edgar","filing":"0001367644-20-000019","document":"wf-form4_158285658301395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000019/wf-form4_158285658301395.xml","form_type":"4"}},{"id":3243405,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-02-28T02:23:21.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":5697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period."}],"balance_after":43634,"source":{"system":"sec-edgar","filing":"0001367644-20-000019","document":"wf-form4_158285658301395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000019/wf-form4_158285658301395.xml","form_type":"4"}},{"id":3243404,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2020-02-28T02:23:21.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":5697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":37937,"source":{"system":"sec-edgar","filing":"0001367644-20-000019","document":"wf-form4_158285658301395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000019/wf-form4_158285658301395.xml","form_type":"4"}},{"id":3596847,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-13T21:10:11.000Z","date":"2019-03-11","kind":"sale","acquired":false,"shares":2430,"price":56.93,"value":138339.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":32240,"source":{"system":"sec-edgar","filing":"0001567619-19-006788","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919006788/doc1.xml","form_type":"4"}},{"id":3618138,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-04T23:40:32.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":2024,"price":58.2,"value":117796.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":34670,"source":{"system":"sec-edgar","filing":"0001567619-19-006067","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919006067/doc1.xml","form_type":"4"}},{"id":3618137,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-04T23:40:32.000Z","date":"2019-02-28","kind":"sale","acquired":false,"shares":1019,"price":57.9218,"value":59022.3142,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price.  These shares were sold in multiple transactions at prices ranging from $57.52 to $58.49, inclusive."}],"balance_after":36694,"source":{"system":"sec-edgar","filing":"0001567619-19-006067","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919006067/doc1.xml","form_type":"4"}},{"id":3625797,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-01T00:38:06.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":20321,"price":61.01,"value":1239784.21,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":20321,"derivative":{"exercise_price":61.01,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":20321},"source":{"system":"sec-edgar","filing":"0001567619-19-005679","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005679/doc1.xml","form_type":"4"}},{"id":3625796,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-01T00:38:06.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":812,"price":58.71,"value":47672.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":37713,"source":{"system":"sec-edgar","filing":"0001567619-19-005679","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005679/doc1.xml","form_type":"4"}},{"id":3625795,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-01T00:38:06.000Z","date":"2019-02-27","kind":"tax_withholding","acquired":false,"shares":409,"price":57.98,"value":23713.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":38525,"source":{"system":"sec-edgar","filing":"0001567619-19-005679","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005679/doc1.xml","form_type":"4"}},{"id":3625794,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-01T00:38:06.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan.  Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period."}],"balance_after":38934,"source":{"system":"sec-edgar","filing":"0001567619-19-005679","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005679/doc1.xml","form_type":"4"}},{"id":3625793,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-01T00:38:06.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":33853,"source":{"system":"sec-edgar","filing":"0001567619-19-005679","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005679/doc1.xml","form_type":"4"}},{"id":3625792,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2019-03-01T00:38:06.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":481,"price":61.01,"value":29345.81,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":28772,"source":{"system":"sec-edgar","filing":"0001567619-19-005679","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005679/doc1.xml","form_type":"4"}},{"id":3773885,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-05T22:03:41.000Z","date":"2018-11-02","kind":"exercise","acquired":true,"shares":6168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":6168},"source":{"system":"sec-edgar","filing":"0001567619-18-005093","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005093/doc1.xml","form_type":"4"}},{"id":3773884,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-05T22:03:41.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":2011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":6168,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":2011},"source":{"system":"sec-edgar","filing":"0001567619-18-005093","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005093/doc1.xml","form_type":"4"}},{"id":3773883,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-11-05T22:03:41.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":6168,"price":64.5,"value":397836.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":29253,"source":{"system":"sec-edgar","filing":"0001567619-18-005093","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005093/doc1.xml","form_type":"4"}},{"id":3773882,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-11-05T22:03:41.000Z","date":"2018-11-02","kind":"exercise","acquired":true,"shares":6168,"price":25.62,"value":158024.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":35421,"source":{"system":"sec-edgar","filing":"0001567619-18-005093","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005093/doc1.xml","form_type":"4"}},{"id":3773881,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-11-05T22:03:41.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":2011,"price":63.5,"value":127698.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":29253,"source":{"system":"sec-edgar","filing":"0001567619-18-005093","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005093/doc1.xml","form_type":"4"}},{"id":3773880,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-11-05T22:03:41.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":2011,"price":25.62,"value":51521.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":31264,"source":{"system":"sec-edgar","filing":"0001567619-18-005093","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005093/doc1.xml","form_type":"4"}},{"id":3783898,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-24T20:25:26.000Z","date":"2018-10-17","kind":"sale","acquired":false,"shares":314,"price":63.5,"value":19939.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This form 4/A is being filed to amend the sales price of the shares."}],"balance_after":29253,"source":{"system":"sec-edgar","filing":"0001567619-18-004474","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004474/doc1.xml","form_type":"4/A","original_submission_date":"2018-10-19"}},{"id":3786294,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-10-19T21:06:25.000Z","date":"2018-10-17","kind":"exercise","acquired":false,"shares":314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":8179,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":314},"source":{"system":"sec-edgar","filing":"0001567619-18-004358","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004358/doc1.xml","form_type":"4"}},{"id":3786293,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-19T21:06:25.000Z","date":"2018-10-17","kind":"sale","acquired":false,"shares":314,"price":61.5,"value":19311.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":29253,"source":{"system":"sec-edgar","filing":"0001567619-18-004358","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004358/doc1.xml","form_type":"4"}},{"id":3786292,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-19T21:06:25.000Z","date":"2018-10-17","kind":"exercise","acquired":true,"shares":314,"price":25.62,"value":8044.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":29567,"source":{"system":"sec-edgar","filing":"0001567619-18-004358","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004358/doc1.xml","form_type":"4"}},{"id":3788047,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-16","kind":"exercise","acquired":false,"shares":3840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":8493,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":3840},"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788046,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-16","kind":"exercise","acquired":false,"shares":6165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":12333,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":6165},"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788045,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-15","kind":"exercise","acquired":false,"shares":6165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":18498,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":6165},"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788044,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-15","kind":"exercise","acquired":false,"shares":6165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":24663,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":6165},"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788043,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-16","kind":"sale","acquired":false,"shares":3840,"price":63.5,"value":243840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":29253,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788042,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-16","kind":"exercise","acquired":true,"shares":3840,"price":25.62,"value":98380.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":33093,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788041,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-16","kind":"sale","acquired":false,"shares":6165,"price":61.5,"value":379147.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":29253,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788040,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-16","kind":"exercise","acquired":true,"shares":6165,"price":25.62,"value":157947.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":35418,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788039,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":661,"price":60.67,"value":40102.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":29253,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788038,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":6165,"price":60.0293,"value":370080.6345,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.67, inclusive."}],"balance_after":29914,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788037,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-15","kind":"exercise","acquired":true,"shares":6165,"price":25.62,"value":157947.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":36079,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788036,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":6165,"price":60.1549,"value":370854.9585,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.31 to $60.67, inclusive."}],"balance_after":29914,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3788035,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-10-17T20:19:50.000Z","date":"2018-10-15","kind":"exercise","acquired":true,"shares":6165,"price":25.62,"value":157947.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":36079,"source":{"system":"sec-edgar","filing":"0001567619-18-004223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918004223/doc1.xml","form_type":"4"}},{"id":3997698,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-13T21:57:35.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":5842,"price":52.82,"value":308574.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.50 to $53.16, inclusive."}],"balance_after":29914,"source":{"system":"sec-edgar","filing":"0001140361-18-013317","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118013317/doc1.xml","form_type":"4"}},{"id":3997697,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-13T21:57:35.000Z","date":"2018-03-09","kind":"tax_withholding","acquired":false,"shares":974,"price":51.84,"value":50492.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":35756,"source":{"system":"sec-edgar","filing":"0001140361-18-013317","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118013317/doc1.xml","form_type":"4"}},{"id":4002834,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-09T22:24:25.000Z","date":"2018-03-07","kind":"exercise","acquired":false,"shares":6573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in three equal installments in March 2012, March 2013 and March 2014.  Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":0,"derivative":{"exercise_price":22.03,"exercise_date":"2014-03-14","expiration_date":"2018-03-14","underlying":"Common Stock","underlying_shares":6573},"source":{"system":"sec-edgar","filing":"0001140361-18-012878","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118012878/doc1.xml","form_type":"4"}},{"id":4002833,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-09T22:24:25.000Z","date":"2018-03-07","kind":"tax_withholding","acquired":false,"shares":2843,"price":50.43,"value":143372.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock option exercise."}],"balance_after":36730,"source":{"system":"sec-edgar","filing":"0001140361-18-012878","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118012878/doc1.xml","form_type":"4"}},{"id":4002832,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-09T22:24:25.000Z","date":"2018-03-07","kind":"exercise","acquired":true,"shares":6573,"price":22.03,"value":144803.19,"ownership":{"direct":true},"balance_after":39573,"source":{"system":"sec-edgar","filing":"0001140361-18-012878","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118012878/doc1.xml","form_type":"4"}},{"id":4023337,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Employee Stock Option (right to buy","published_at":"2018-03-01T22:03:06.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":20145,"price":49.64,"value":999997.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments on February 26, 2019, February 26, 2020 and February 26, 2021."}],"balance_after":20145,"derivative":{"exercise_price":49.64,"expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":20145},"source":{"system":"sec-edgar","filing":"0001140361-18-011285","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011285/doc1.xml","form_type":"4"}},{"id":4023336,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-01T22:03:06.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":1898,"price":49.5,"value":93951.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001140361-18-011285","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011285/doc1.xml","form_type":"4"}},{"id":4023335,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-01T22:03:06.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":811,"price":49.97,"value":40525.67,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":34898,"source":{"system":"sec-edgar","filing":"0001140361-18-011285","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011285/doc1.xml","form_type":"4"}},{"id":4023334,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-01T22:03:06.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":409,"price":49.64,"value":20302.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":35709,"source":{"system":"sec-edgar","filing":"0001140361-18-011285","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011285/doc1.xml","form_type":"4"}},{"id":4023333,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-01T22:03:06.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":5036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":36118,"source":{"system":"sec-edgar","filing":"0001140361-18-011285","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011285/doc1.xml","form_type":"4"}},{"id":4023332,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2018-03-01T22:03:06.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":5036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":31082,"source":{"system":"sec-edgar","filing":"0001140361-18-011285","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011285/doc1.xml","form_type":"4"}},{"id":4198997,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-29T20:52:56.000Z","date":"2017-09-27","kind":"exercise","acquired":false,"shares":7885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":22.03,"expiration_date":"2018-03-14","underlying":"Common Stock","underlying_shares":7885},"source":{"system":"sec-edgar","filing":"0001140361-17-036981","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117036981/doc1.xml","form_type":"4"}},{"id":4198996,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2017-09-29T20:52:56.000Z","date":"2017-09-27","kind":"sale","acquired":false,"shares":7885,"price":39.5,"value":311457.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":26046,"source":{"system":"sec-edgar","filing":"0001140361-17-036981","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117036981/doc1.xml","form_type":"4"}},{"id":4198995,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2017-09-29T20:52:56.000Z","date":"2017-09-27","kind":"exercise","acquired":true,"shares":7885,"price":22.03,"value":173706.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":33931,"source":{"system":"sec-edgar","filing":"0001140361-17-036981","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117036981/doc1.xml","form_type":"4"}},{"id":4211366,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-12T19:56:56.000Z","date":"2017-09-08","kind":"exercise","acquired":false,"shares":7885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":7885,"derivative":{"exercise_price":22.03,"expiration_date":"2018-03-14","underlying":"Common Stock","underlying_shares":7885},"source":{"system":"sec-edgar","filing":"0001140361-17-035190","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117035190/doc1.xml","form_type":"4"}},{"id":4211365,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2017-09-12T19:56:56.000Z","date":"2017-09-08","kind":"sale","acquired":false,"shares":7885,"price":37.0631,"value":292242.5435,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.87 to $37.59, inclusive."}],"balance_after":26046,"source":{"system":"sec-edgar","filing":"0001140361-17-035190","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117035190/doc1.xml","form_type":"4"}},{"id":4211364,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Operations"}}],"security":"Common Stock","published_at":"2017-09-12T19:56:56.000Z","date":"2017-09-08","kind":"exercise","acquired":true,"shares":7885,"price":22.03,"value":173706.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."}],"balance_after":33931,"source":{"system":"sec-edgar","filing":"0001140361-17-035190","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117035190/doc1.xml","form_type":"4"}},{"id":4360093,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Biodefense Divison"}}],"security":"Common Stock","published_at":"2017-04-04T20:14:36.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":11419,"price":28.6197,"value":326808.3543,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.50 to $29.19, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":26046,"source":{"system":"sec-edgar","filing":"0001140361-17-014647","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117014647/doc1.xml","form_type":"4"}},{"id":4382058,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Biodefense Divison"}}],"security":"Common Stock","published_at":"2017-03-16T15:28:57.000Z","date":"2017-03-15","kind":"gift","acquired":false,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of issuer common stock by the reporting person to a charitable gift fund."}],"balance_after":37465,"source":{"system":"sec-edgar","filing":"0001140361-17-012231","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117012231/doc1.xml","form_type":"4"}},{"id":4390462,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Biodefense Divison"}}],"security":"Common Stock","published_at":"2017-03-11T02:38:26.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":1624,"price":31.05,"value":50425.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":39265,"source":{"system":"sec-edgar","filing":"0001140361-17-011684","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117011684/doc1.xml","form_type":"4"}},{"id":4390461,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112375,"kind":"person","name":"Havey Adam","position":1,"cik":"0001514588","reported_name":"Havey Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Biodefense Divison"}}],"security":"Common Stock","published_at":"2017-03-11T02:38:26.000Z","date":"2017-03-09","kind":"tax_withholding","acquired":false,"shares":1076,"price":30.98,"value":33334.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":40889,"source":{"system":"sec-edgar","filing":"0001140361-17-011684","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117011684/doc1.xml","form_type":"4"}}],"next_cursor":"2017-03-11T02:38:26.000000Z,4390461"}